Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Mariam Elmegaard

Showing results (21-30 of 36) with videos related to

Pageof 4
Sort By:
European Heart Journal. Acute Cardiovascular Care|August 1, 2025
Long-term outcomes of recurrent myocardial infarction: a nationwide Danish studyDaniel Mølager Christensen, Deewa Zahir, Caroline Hartwell Garred, et al.
Journal of the American Heart Association|April 9, 2026
Care and Outcomes of New-Onset Heart Failure Across Vulnerable Populations: Temporal Trends in Mortality and Treatment in a Danish Nationwide Cohort From 2003 to 2022Sofie-Louise Feentved Ødum, Clara Friis, Caroline Hartwell Garred, et al.
The Lancet. Healthy Longevity|May 5, 2024
Age-specific mortality trends in heart failure over 25 years: a retrospective Danish nationwide cohort studyCaroline Hartwell Garred, Morten Malmborg, Mariam Elmegaard Malik, et al.
The Lancet. Healthy Longevity|September 21, 2023
Initiation of SGLT2 inhibitors and GLP-1 receptor agonists according to level of frailty in people with type 2 diabetes and cardiovascular disease in Denmark: a cross-sectional, nationwide studyMariam Elmegaard Malik, Jawad Haider Butt, Jarl Emanuel Strange, et al.
ESC Heart Failure|November 6, 2024
Prognostic impact of iron deficiency in new-onset chronic heart failure: Danish Heart Failure Registry insightsAbdullahi Ahmed Mohamed, Daniel Mølager Christensen, Milan Mohammad, et al.
Heart (British Cardiac Society)|February 8, 2025
Prognostic implications of iron deficiency in patients with atrial fibrillation, with and without chronic heart failureAbdullahi Ahmed Mohamed, Daniel Mølager Christensen, Milan Mohammad, et al.
The Lancet. Diabetes & Endocrinology|December 28, 2020
Effects of empagliflozin on estimated extracellular volume, estimated plasma volume, and measured glomerular filtration rate in patients with heart failure (Empire HF Renal): a prespecified substudy of a double-blind, randomised, placebo-controlled trialJesper Jensen, Massar Omar, Caroline Kistorp, et al.
Journal of the American Heart Association|February 3, 2025
Temporal Trends in Mortality and Hospitalization Risk in Patients With Heart Failure According to the Hospital Frailty Risk ScoreNoor K Abassi, Nina Nouhravesh, Mariam Elmegaard, et al.
ESC Heart Failure|July 9, 2024
Incidence of clinical outcomes in heart failure patients with and without advanced chronic kidney diseaseDeewa Zahir Anjum, Anders N Bonde, Emil Fosbol, et al.
European Heart Journal|November 18, 2025
Temporal trends in the use of oral anticoagulants and clinical outcomes in older, elderly, and very elderly patients with atrial fibrillation: a Danish nationwide studyCasper Binding, Mariam Elmegaard, Simon Larsen, et al.
Pageof 4

Showing results (21-30 of 36) with videos related to

Sort By:
Pageof 4
European Heart Journal. Acute Cardiovascular Care|August 1, 2025
Long-term outcomes of recurrent myocardial infarction: a nationwide Danish studyDaniel Mølager Christensen, Deewa Zahir, Caroline Hartwell Garred, et al.
Journal of the American Heart Association|April 9, 2026
Care and Outcomes of New-Onset Heart Failure Across Vulnerable Populations: Temporal Trends in Mortality and Treatment in a Danish Nationwide Cohort From 2003 to 2022Sofie-Louise Feentved Ødum, Clara Friis, Caroline Hartwell Garred, et al.
The Lancet. Healthy Longevity|May 5, 2024
Age-specific mortality trends in heart failure over 25 years: a retrospective Danish nationwide cohort studyCaroline Hartwell Garred, Morten Malmborg, Mariam Elmegaard Malik, et al.
The Lancet. Healthy Longevity|September 21, 2023
Initiation of SGLT2 inhibitors and GLP-1 receptor agonists according to level of frailty in people with type 2 diabetes and cardiovascular disease in Denmark: a cross-sectional, nationwide studyMariam Elmegaard Malik, Jawad Haider Butt, Jarl Emanuel Strange, et al.
ESC Heart Failure|November 6, 2024
Prognostic impact of iron deficiency in new-onset chronic heart failure: Danish Heart Failure Registry insightsAbdullahi Ahmed Mohamed, Daniel Mølager Christensen, Milan Mohammad, et al.
Heart (British Cardiac Society)|February 8, 2025
Prognostic implications of iron deficiency in patients with atrial fibrillation, with and without chronic heart failureAbdullahi Ahmed Mohamed, Daniel Mølager Christensen, Milan Mohammad, et al.
The Lancet. Diabetes & Endocrinology|December 28, 2020
Effects of empagliflozin on estimated extracellular volume, estimated plasma volume, and measured glomerular filtration rate in patients with heart failure (Empire HF Renal): a prespecified substudy of a double-blind, randomised, placebo-controlled trialJesper Jensen, Massar Omar, Caroline Kistorp, et al.
Journal of the American Heart Association|February 3, 2025
Temporal Trends in Mortality and Hospitalization Risk in Patients With Heart Failure According to the Hospital Frailty Risk ScoreNoor K Abassi, Nina Nouhravesh, Mariam Elmegaard, et al.
ESC Heart Failure|July 9, 2024
Incidence of clinical outcomes in heart failure patients with and without advanced chronic kidney diseaseDeewa Zahir Anjum, Anders N Bonde, Emil Fosbol, et al.
European Heart Journal|November 18, 2025
Temporal trends in the use of oral anticoagulants and clinical outcomes in older, elderly, and very elderly patients with atrial fibrillation: a Danish nationwide studyCasper Binding, Mariam Elmegaard, Simon Larsen, et al.
Pageof 4